fMRI of Language Recovery Following Stroke in Adults
The purpose of this study is to learn how language difficulties caused by stroke improve and test the effectiveness of constraint-induced aphasia therapy.
|Study Design:||Observational Model: Case-Only
Time Perspective: Prospective
|Official Title:||fMRI of Language Recovery Following Stroke in Adults|
- Primary outcome measure is aphasia improvement. In young and old adults, longitudinal changes in language activation patterns will be mapped & language localization and lateralization will be determined using fMRI after stroke [ Time Frame: 2 weeks after stroke, at 5-6 weeks, 3 months, 6 months and 12 months ] [ Designated as safety issue: No ]
- In participants with stroke, changes in language activation will be mapped using fMRI [ Time Frame: 2 weeks after stroke, at 5-6 weeks, 3 months, 6 months and 12 months ] [ Designated as safety issue: No ]
- CIAT will be applied & fMRI & neuropsychological measures will be used to document the relationship between the clinical and anatomical correlates of post-stroke language recovery in people with stroke [ Time Frame: 2 weeks or at 5-6 weeks after stroke , 3 months, 6 months and 12 months ] [ Designated as safety issue: No ]
|Study Start Date:||September 2008|
|Estimated Study Completion Date:||July 2014|
|Estimated Primary Completion Date:||July 2014 (Final data collection date for primary outcome measure)|
The aphasia group will have left middle cerebral artery (LMCA) stroke with moderate aphasia.
The control group will be healthy with no aphasia or stroke.
Aphasia (difficulty speaking) is one of the most dreaded consequences of stroke. It is associated with high mortality and severe motor, social, and cognitive disability. During the past decade, therapies administered by stroke teams have made great strides in limiting the damage due to a stroke. Unfortunately, progress in aphasia rehabilitation has not experienced the same rapid advancement. Evidence suggests that the brain may have untapped potential for recovery of aphasia after stroke.
Using functional magnetic resonance imaging (fMRI), researchers now are able to examine the areas of the brain that are responsible for language recovery after stroke. Such data may explain how the brain recovers after stroke, and may lead to new therapies to help individuals who have suffered an aphasia-causing stroke.
In this study, researchers will examine the changes the brain undergoes while recovering from an aphasia-causing stroke and the mechanisms that underlie such recovery, and test the effectiveness of a new and promising method of aphasia rehabilitation called constraint-induced aphasia therapy (CIAT). The scientists will perform fMRI studies of brain activation in people who have suffered an aphasia-causing stroke in order to better understand the underlying mechanisms of recovery from aphasia. Specifically the researchers will compare language activation between adults with stroke and children with perinatal and postnatal stroke (from previous studies); map changes in language activation, characterize the patterns of language reorganization that occur following stroke; and use the fMRI measures to assess recovery using CIAT.
The study will last one year, during this time participants will have language testing to evaluate the degree of aphasia and its recovery; and five fMRI scans scheduled at 2 weeks, 6 weeks, 12 weeks, 26 weeks, and 56 weeks. Participants with remaining moderate aphasia will be offered a chance to participate in an extension treatment study that will last up to 3 months.
A better understanding of brain changes during recovery from aphasia may help develop new methods to improve recovery.
|Contact: Jerzy Szaflarskiemail@example.com|
|United States, Alabama|
|University of Alabama at Birmingham||Recruiting|
|Birmingham, Alabama, United States, 35294|
|Contact: Jerzy Szaflarski, MD, PhD 205-934-3866 firstname.lastname@example.org|
|Contact: Amber Martin 205-934-3866 email@example.com|
|Principal Investigator: Jerzy P. Szaflarski, MD, PhD|
|Principal Investigator:||Jerzy P. Szaflarski, MD, PhD||University of Alabama at Birmingham, Department of Neurology|